BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26301616)

  • 1. Normal Growth and Essential Fatty Acid Status in Children With Intestinal Failure on Lipid Limitation.
    Lam G; Strogach IG; Baron N; Thompson JF
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):335-40. PubMed ID: 26301616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency.
    Gunnar R; Lumia M; Pakarinen M; Merras-Salmio L
    JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1203-1210. PubMed ID: 29701873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
    Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients.
    de Meijer VE; Le HD; Meisel JA; Gura KM; Puder M
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):212-8. PubMed ID: 20038849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study.
    Rollins MD; Ward RM; Jackson WD; Mulroy CW; Spencer CP; Ying J; Greene T; Book LS
    J Pediatr Surg; 2013 Jun; 48(6):1348-56. PubMed ID: 23845629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Fatty Acid Deficiency in 2015: The Impact of Novel Intravenous Lipid Emulsions.
    Gramlich L; Meddings L; Alberda C; Wichansawakun S; Robbins S; Driscoll D; Bistrian B
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(1 Suppl):61S-6S. PubMed ID: 26187936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Doses of Fish Oil-Based Lipid Emulsions Used to Treat Inadequate Weight Gain and Rising Triene:Tetraene Ratio in a Severely Malnourished Infant With Intestinal Failure-Associated Liver Disease.
    Riedy M; DePaula B; Puder M; Gura KM; Sztam KA
    JPEN J Parenter Enteral Nutr; 2017 May; 41(4):667-671. PubMed ID: 27484488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
    Khan FA; Fisher JG; Sparks EA; Potemkin A; Duggan C; Raphael BP; Modi BP; Jaksic T
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
    Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
    Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential Fatty Acid Status in Surgical Infants Receiving Parenteral Nutrition With a Composite Lipid Emulsion: A Case Series.
    Carey AN; Rudie C; Mitchell PD; Raphael BP; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):305-310. PubMed ID: 29846008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease.
    Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Dao DT; Fell GL; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):71-77. PubMed ID: 29505154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Complications Associated with Parenteral Nutrition in Preterm Infants < 32 Weeks with a Mixed Oil Lipid Emulsion vs a Soybean Oil Lipid Emulsion in a Level IV Neonatal Intensive Care Unit.
    Franco S; Goriacko P; Rosen O; Morgan-Joseph T
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1204-1212. PubMed ID: 32862507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease.
    Gura K; Premkumar MH; Calkins KL; Puder M
    J Pediatr; 2020 Apr; 219():98-105.e4. PubMed ID: 32059815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.
    Gura KM; Premkumar MH; Calkins KL; Puder M
    J Pediatr; 2021 Mar; 230():46-54.e2. PubMed ID: 33038344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential Fatty Acid Deficiency with SMOFlipid Reduction in an Infant with Intestinal Failure-Associated Liver Disease.
    Memon N; Hussein K; Hegyi T; Herdt A; Griffin IJ
    JPEN J Parenter Enteral Nutr; 2019 Mar; 43(3):438-441. PubMed ID: 30088831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential fatty acid deficiency during parenteral soybean oil lipid minimization.
    Ernst KD
    J Perinatol; 2017 Jun; 37(6):695-697. PubMed ID: 28333161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Fish Oil and Serum Fatty Acid Profiles in Pediatric Patients With Intestinal Failure-Associated Liver Disease.
    Ong ML; Venick RS; Shew SB; Dunn JCY; Reyen L; Grogan T; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):717-725. PubMed ID: 30900274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Smoflipid® and Intralipid® in the Early Management of Infants with Intestinal Failure.
    Casson C; Nguyen V; Nayak P; Channabasappa N; Berris K; Panczuk J; Bhiladvala C; Dasgupta T; Piper HG
    J Pediatr Surg; 2020 Jan; 55(1):153-157. PubMed ID: 31672409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.